Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Clinical trial NCT03994796 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03994796
Sponsor: Alliance for Clinical Trials in Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CDK Gene Mutation Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Solid Neoplasm NTRK Family Gene Mutation PI3K Gene Mutation ROS1 Gene Mutation KRAS G12C Mutation

Start date: 2019-10-17
Primary completion: 2026-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.